首页> 外文期刊>Acta biomaterialia >Cross-linked electrospun cartilage acellular matrix/poly(caprolactone-co-lactide-co-glycolide) nanofiber as an antiadhesive barrier
【24h】

Cross-linked electrospun cartilage acellular matrix/poly(caprolactone-co-lactide-co-glycolide) nanofiber as an antiadhesive barrier

机译:交联静电纺厂软骨甲状腺基质/聚(己内酯 - 共丙交酯 - 共乙醚)纳米纤维作为抗粘附屏障

获取原文
获取原文并翻译 | 示例

摘要

In this work, we chose cartilage acellular matrix (CAM) as a promising antiadhesive material because CAM effectively inhibits the formation of blood vessels, and we used electrospinning to prepare antiadhesive barriers. Additionally, we synthesized N-hydroxysuccinimide (NHS)-poly(caprolactone-co-lactideco-glycolide)-NHS (MP) copolymers (to tune degradation) as a cross-linking agent for CAM. This is the first report on the development of electrospun cross-linked (Cx) CAM/MP (CA/P) nanofiber (NF) (CxCA/P-NF) with a tunable degradation period as an antiadhesive barrier. Compared with the CA/P-NF before cross-linking, the electrospun Cx-CA/P-NF after cross-linking showed different biodegradation. Cx-CA/P-NF significantly inhibited the in vitro attachment and proliferation of human umbilical vein endothelial cells (HUVECs), as confirmed by an MIT assay and scanning electron microscopy images. Cx-CA/P-NFs implanted between a surgically damaged peritoneal wall and cecum gradually degraded in 7 days; this process was monitored by NIR imaging. The in vivo evaluation of the anti-tissue adhesive effect of Cx-CA/P-NFs revealed little adhesion, few blood vessels, and negligible inflammation at 7 days determined by hematoxylin and eosin staining. ED1 staining of Cx-CA/P-NFs showed infiltration of few macrophages because of the inflammatory response to the Cx-CA/P-NF as compared with an untreated injury model. Additionally, Cx-CA/P-NFs significantly suppressed the formation of blood vessels between the peritoneal wall and cecum, according to CD31 staining. Overall, Cx-CA/P-NFs yielded little adhesion, infiltration by macrophages, or formation of blood vessels in a postoperative antiadhesion assay. Thus, it is reasonable to conclude that the Cx-CA/P-NF designed herein successfully works as an antiadhesive barrier with a tunable degradation period.
机译:在这项工作中,我们选择了软骨缩小基质(CAM)作为有充满希望的抗粘附材料,因为CAM有效地抑制了血管的形成,并且我们用静电纺丝制备抗粘附障碍。另外,我们合成了N-羟基琥珀酰亚胺(NHS)-Pold(己内酯 - 共聚乙酰乙酰乙酰乙酰酯)-NHS(MP)共聚物(以调度降解)作为凸轮的交联剂。这是关于Electrom ow交联(CX)CAM / MP(CA / P)纳米纤维(NF)(CXCA / P-NF)的第一个报告,其可调谐降解期作为抗粘附屏障。与交联之前的CA / P-NF相比,交联后的Electrom ow CX-CA / P-NF显示出不同的生物降解。 CX-CA / P-NF显着抑制人脐静脉内皮细胞(HUVECS)的体外附着和增殖,如通过麻省理工学院测定和扫描电子显微镜图像证实。植入手术损伤腹膜壁和盲肠之间的CX-CA / P-NFS在7天内逐渐降解;通过NIR成像监测该过程。体内评价CX-CA / P-NFS的抗组织粘合剂效果显示出几乎粘附,血管少量血管,7天通过苏木精和曙红染色测定的可忽略炎症。由于与未处理的损伤模型相比,CX-CA / P-NFS的ED1染色显示出少数巨噬细胞的渗透性。另外,根据CD31染色,CX-CA / P-NFS显着抑制了腹膜壁和盲肠之间的血管的形成。总体而言,CX-CA / P-NFS产生很少的粘附性,巨噬细胞渗透,或在术后抗粘附测定中形成血管。因此,得出结论是合理的,结论本文设计的CX-CA / P-NF成功地用作可调谐降解期间的抗粘附屏障。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号